Clinical trial

BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies

NCT03269175

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-09-29

PhasePHASE4

Study timeline

Study start (actual)2017-09-29Date precision: day

Registry last updated2019-05-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Brain MRIOTHER

Blood samplingOTHER

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

BarcelonaSpain2 MontrealQuebec, Canada2 BudapestHungary2 LondonUnited Kingdom1 BerlinGermany1 ValenciaSpain1 PragueCzechia1 OttawaOntario, Canada1 LilleFrance1 BordeauxFrance1 LeuvenBelgium1 KrakowPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03269175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.